1. Greenhill, J. V. In Comprehensive Heterocyclic Chemistry; Katritzky,
A. R., Rees, C. W., Bird, C. W., Cheeseman, G. W. H., Eds.;
Pergamon Press: Oxford, 1984; Vol. 4.
2. Kam, T.-S.; Sim, K.-M. Phytochemistry 1998, 47, 145–147.
3. Rabindran, S. K.; Ross, D. D.; Doyle, L. A.; Yang, W.; Greenberger,
L. M. Cancer Res. 2000, 60, 47–50.
4. Patil, A. D.; Freyer, A. J.; Carte, B.; Taylor, P. B.; Johnson, R. K.;
Faulkner, D. J. J. Nat. Prod. 2002, 65, 628–629.
5. For recent illustrative examples of the use of THBCs in drug
discovery, see: (a) Trujillo, J. I.; Meyers, M. J.; Anderson, D. R.;
Hegde, S.; Mahoney, M. W.; Vernier, W. F.; Buchler, I. P.; Wu, K.
K.; Yang, S.; Hartmann, S. J.; Reitz, D. B. Bioorg. Med. Chem. Lett.
2007, 17, 4657–4663; (b) Chen, C.-H.; Chang, C.-M.; Chen, H.-Y.;
Lai, J.-J.; Sun, C.-M. J. Comb. Chem. 2007, 9, 618–626; (c) Diness, F.;
Beyer, J.; Meldal, M. Chem. Eur. J. 2006, 12, 8056–8066; (d) Lee,
S.-C.; Choi, S. Y.; Chung, Y. K.; Park, S.-B. Tetrahedron Lett. 2006,
47, 6843–6847; (e) Sunder-Plassmann, N.; Sarli, V.; Gartner, M.; Utz,
M.; Seiler, J.; Huemmer, S.; Mayer, T. U.; Surrey, T.; Giannis, A.
Bioorg. Med. Chem. Lett. 2005, 13, 6094–6111.
6. (a) Daugan, A.; Grondin, P.; Ruault, C.; Le Monnier de Gouville,
A.-C.; Coste, H.; Kirilovsky, J.; Hyafil, F.; Labaudinie`re, R. J. Med.
Chem. 2003, 46, 4525–4532; (b) Daugan, A.; Grondin, P.; Ruault, C.;
Le Monnier de Gouville, A.-C.; Coste, H.; Linget, J.-M.; Kirilovsky,
J.; Hyafil, F.; Labaudinie`re, R. J. Med. Chem. 2003, 46, 4533–4542.
7. Herraiz, T.; Galisteo, J.; Chamorro, C. J. Agric. Food Chem. 2003, 51,
2168–2173.
8. For a review, see: Cox, E. D.; Cook, J. M. Chem. Rev. 1995, 95, 1797–
1842.
9. For alternative strategies to THBCs, see: Bandini, M.; Melloni, A.;
Piccinelli, F.; Sinisi, R.; Tommasi, S.; Umani-Ronchi, A. J. Am.
Chem. Soc. 2006, 128, 1424–1425 and references cited therein.
10. Lingam, Y.; Rao, D. M.; Bhowmik, D. R.; Santu, P. S.; Rao, K. R.;
Islam, A. Tetrahedron Lett. 2007, 48, 7243–7245.
11. Horiguchi, Y.; Nakamura, M.; Kida, A.; Kodama, H.; Saitoh, T.;
Sano, T. Heterocycles 2003, 59, 691–705.
12. Shiers, J. J.; Shipman, M.; Hayes, J. F.; Slawin, A. M. Z.; Twin, H. J.
Am. Chem. Soc. 2004, 126, 6868–6869 and references cited therein.
13. Prepared by adaption of a recent synthesis of N-benzyltryptamine by:
Liu, Y.; Luo, S.; Fu, X.; Fang, F.; Zhuang, Z.; Xiong, W.; Jia, X.;
Zhai, H. Org. Lett. 2006, 8, 115–118.
14. Hayes, J. F.; Shipman, M.; Twin, H. J. Org. Chem. 2002, 67, 935–942.
15. Strong NOESY cross-peaks were seen between the Me group at C-1
and H-3, and between the CH2OBn group and the methyl group at
C-3. These data are consistent with the depicted (1R*,3R*)-
diastereomer.